Follow-up after partial or total nephrectomy for renal cell carcinoma.
Salvage therapy is not readily available to patients with recurrent renal cell carcinoma. Selected solitary metastases may be resected, a tumor on the contralateral kidney may be excised, or the patient may be amenable to systemic biologic response modifier therapy. More commonly, only palliative therapy is available, and follow-up is tailored with the former considerations in mind. Early investigation of symptoms may minimize later morbidity from metastases to the brain or bone. A proposed follow-up schedule is presented.
Montie
J E
JE
Department of Urology, Wayne State University School of Medicine, Detroit, Michigan.
D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000453:epidemiology / Q000556:secondary / Q000601:surgery*; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000601:surgery*; D009392:Nephrectomy; D012307:Risk Factors; D013997:Time Factors